Page 328 - Problem-Based Feline Medicine
P. 328

320   PART 6   CAT WITH WEIGHT LOSS OR CHRONIC ILLNESS


          lymphosarcoma, hyperthyroidism and the other  Prognosis
          malassimilation syndromes should be considered as
                                                        Prognosis depends on the severity of damage. Many
          important differentials.
                                                        cats live with low-grade smoldering pancreatitis for
          Treatment                                     many years, however, once exocrine pancreatic insuffi-
                                                        ciency and/or diabetes has developed the prognosis is
          (For treatment of acute pancreatitis see page 277, The  worse.
          Cat With Depression, Anorexia or Dehydration)
                                                        In rare cases of congenital exocrine pancreatic insuffi-
          Replace pancreatic enzymes by adding pancreatic  ciency, the prognosis is good, as long as the cat receives
          enzyme replacement to food (~ half a teaspoonful of  pancreatic supplementation.
          powder per meal, or to effect), or add fresh-frozen then
          defrosted pig pancreas (~20–40 g per meal, or to effect).
                                                        Prevention
          Immunosuppression: In the non-suppurative form of
                                                        Since it is not known what triggers pancreatitis to
          pancreatitis, immunosuppressive doses of  corticos-
                                                        develop, it is not currently possible to prevent its onset.
          teroids may be needed to reduce ongoing inflammation
                                                        However, since chronic pancreatitis can progress to
          (prednisolone 1–4 mg/kg q 12–24 hours PO, then taper
                                                        exocrine pancreatic insufficiency, it would appear sen-
          over 1–3 months and maintain on every other day doses
                                                        sible to try to control it as well as possible to try to pre-
          if needed). Alternately, chlorambucil could be consid-
                                                        vent its progression.
                      2
          ered (2–5 mg/m PO up to once every 48 h).
          Supportive therapies:
          ● Feed a highly digestible, “bland enteric diet”,
                                                        LYMPHOCYTIC CHOLANGIOHEPATITIS*
            which is low in fat. Feed small meals frequently.
          ● Cobalamin is often reduced by lack of pancreatic
                                                         Classical signs
            intrinsic factor and malabsorption and should be
            supplemented (125–250 μg/week SC or IM for 6–8  ● Typically seen in middle-aged cats, and
            weeks or 50–100 μg/cat/day PO).                Persian cats may be over-represented.
          ● Vitamin K1 is often required because fat malab-  ● Weight loss, inappetence, some cats may
            sorption results in poor absorption of fat-soluble  be polyphagic,
            vitamins like vitamin K, and this can result in  ● ± mild generalized lymphadenopathy,
            abnormal hemostasis (0.5 mg/kg/day SC for 3–4  ● ± vomiting and/or diarrhea.
            days, then once weekly).                     ● In some cats, is associated with IBD and/or
          ● Vitamin E may be given for its anti-oxidative prop-  pancreatitis.
            erties (50–200 IU/cat/day PO).
          Surgical intervention may be required if complete
                                                        Pathogenesis
          biliary obstruction occurs (cholecystotomy or cholecys-
          toduodenostomy), or if a focal pancreatic mass is  The  cholangitis/cholangiohepatitis complex com-
          detected (partial pancrectomy to remove a pancreatic  prises chronic non-suppurative (lymphocytic) cholangi-
          pseudocyst, abscess, fibrotic mass or tumor).  tis/cholangiohepatitis, suppurative cholangitis/cholan-
                                                        giohepatitis and biliary cirrhosis.
          Diabetes that develops secondary to chronic pancreati-
                                                         ● The pathogenesis and interaction of the three condi-
          tis can be very difficult to stabilize. Insulin require-
                                                           tions is poorly understood and it is highly probably
          ments may vary widely because of the ongoing
                                                           that each of these conditions incorporates a number of
          pancreatic pathology, and treatment is complicated fur-
                                                           different diseases.
          ther when corticosteroids also need to be given.
                                                         ● Cholangitis describes inflammation of the biliary
          It is essential to diagnose and treat any concurrent dis-  tract, while cholangiohepatitis describes inflamma-
          ease (e.g. IBD and/or cholangitis/cholangiohepatitis  tion of the peribiliary hepatocytes as well as the bil-
          complex).                                        iary tract.
   323   324   325   326   327   328   329   330   331   332   333